Fundraising FoxSolasta Ventures — 2023 Investments
4 investments dated 2023 · listed companies and verified rows first · show all
EvolveImmune develops immunotherapy treatments for cancer patients.
BiotechHealthtechMedical DevicesBranford, US
Stephen Bloch(Co-founder and Chief Executive Officer)inDonmienne Leung(Manager)Ian Taylor(Manager)Jay Fine(President, Research and Development)
BoardDerek Yoon(Manager)inJasmina Marjanovic(Manager)in
Co-investorsPfizer VenturesElm Street VenturesPfizer Venture InvestmentsTakeda Ventures
Boxhub operates an online marketplace for buying and selling shipping containers, modernizing the traditionally fragmented container trade through digital technology.
B2B MarketplacesE-commerceLogistics & Supply Chain
Maxmillian Birner(Co-Founder & CEO)Maximilian Birner(Founder)inMax Birner(Founder)Niklas Östberg(Founder)Philip Skov(Founder)
Co-investorsAlleyCorpFJ LabsInterplay Ventures Early Stage Management LlcAlley Robotics VenturesHum CapitalMotion Ventures
Ensoma is a genomic medicine company developing a platform for in vivo engineering of hematopoietic stem cells (HSCs), combining an off-the-shelf delivery system with a gene engineering toolkit intended to treat diseases with a one-time treatment.
BiotechHealthtechMedical DevicesBoston, US
Albert Seymour(Director)
BoardKush Parmar(Executive Officer, Director)inPaula Soteropoulos(Director)Stephen Knight(Director)in
Co-investors5AM VenturesAju IB InvestmentCatalio Capital Management, LPDelos CapitalF-Prime CapitalViking Global+10 more
Prime Roots makes plant-based deli meats designed to match conventional meat in blind taste tests, using clean ingredients without nitrates or celery salt.
ConsumerFoodTech
Kimberlie Le(Founder)inJoshua Nixon(Founder)
Co-investorsAlumni VenturesCollaborative FundDiamond Edge VenturesDnx VenturesGaingelsPangaea Ventures Us Inc.+9 more
__Twitter.png)
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.